A phase III trial of AFX3772
Latest Information Update: 30 Sep 2022
At a glance
- Drugs AFX 3772 (Primary)
- Indications Pneumococcal infections
- Focus Registrational; Therapeutic Use
Most Recent Events
- 30 Sep 2022 New trial record
- 16 Aug 2022 According to a GlaxoSmithKline media release, preparation for phase III trial are underway.